French doctors are told to restrict use of third and fourth generation oral contraceptivesBMJ 2013; 346 doi: http://dx.doi.org/10.1136/bmj.f121 (Published 08 January 2013) Cite this as: BMJ 2013;346:f121
- Sophie Arie
France is taking steps to stop the overprescription of third and fourth generation oral contraceptives after a legal case highlighted the fact that many women are running an increased risk of serious side effects by taking the pills when alternatives are available.
In the first case of its kind in France, Marion Larat, 25, sued the German drug company Bayer and the head of the French drug regulatory board, the Agence Nationale de Sécurité du Médicament et des Produits de Santé (ANSM), in December after she had a stroke while taking Bayer’s third generation …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial